Company intelligence / Profile preview

Tennr

New York, New York, United Statestennr.com ↗

Ownership: Private
Development stage: Commercial

Overview

Tennr has developed and commercialized an AI-powered automation platform, leveraging its proprietary RaeLM™ vision-language model to automate referral management, patient intake, and insurance documentation workflows in healthcare. The technology is reported to reduce patient processing times from weeks to hours and cut first-time insurance denials by up to 98% for customers. The company has processed millions of patients across hundreds of practices in the US. No clinical trial results are relevant as this is a health tech/software company.

Modalities: Non-pharmacological therapy (automation platform; not a drug/biologic company)
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Tennr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tennr.

Explore the full profile